骨骼肌松弛药的药物-药物-药物三重相互作用与意外创伤:信号检测
本研究对美国商业及Medicare Advantage健康计划成员2000-2019年医疗数据进行高通量药物流行病学筛查,采用自身对照病例系列设计,评估骨骼肌松弛药(SMR)为基础配对联合第三种药物时与意外创伤发生率的关系。在58 478个药物三联体中,29个与损伤显著正相关,校正后率比范围为1.39至2.23,多数信号为新发现。
要点
- 29个SMR三联体信号与意外创伤发生率升高显著相关。
- 最高信号为替扎尼定+双氯芬酸+阿普唑仑,校正RR=2.23。
- 多数识别出的三重相互作用信号尚未被正式研究。
核心结论
- 识别出29个与损伤率升高相关的骨骼肌松弛药三重相互作用信号。
- 未来病因学研究应确认或反驳这些信号。
研究设计与样本
- 采用自动化高通量药物流行病学筛查,数据为2000-2019年美国商业及Medicare Advantage健康计划成员医疗数据。
- 对每个药物三联体进行自身对照病例系列研究,纳入年龄≥16岁且在基础配对暴露观察期内发生损伤的患者。
- 使用条件Poisson回归计算校正率比及95%置信区间。
主要发现
- 在58 478个三联体中,29个与损伤显著正相关。
- 校正后率比范围从替扎尼定+奥美拉唑联合加巴喷丁的1.39(95%CI=1.01-1.91)到替扎尼定+双氯芬酸联合阿普唑仑的2.23(95%CI=1.02-4.87)。
- 大多数识别出的三重相互作用信号是新发现的,尚未被正式研究。
临床怎么用
- 临床药师在审核骨骼肌松弛药联合用药时,应关注已识别的29个三联体信号。
- 对使用SMR基础配对并叠加第三种药物的患者,需警惕意外创伤风险。
局限性
- 研究为信号检测性质,不能确立因果关系。
- 多数信号为新发现,需未来病因学研究确认或反驳。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The aim of this study was to identify skeletal muscle relaxant (SMR) drug-drug-drug interaction (3DI) signals associated with increased rates of unintentional traumatic injury. METHODS: We conducted automated high-throughput pharmacoepidemiologic screening of 2000-2019 healthcare data for members of United States commercial and Medicare Advantage health plans. We performed a self-controlled case series study for each drug triad consisting of an SMR base-pair (i.e., concomitant use of an SMR with another medication), and a co-dispensed medication (i.e., candidate interacting precipitant) taken during ongoing use of the base-pair. We included patients aged ≥16 years with an injury occurring during base-pair-exposed observation time. We used conditional Poisson regression to calculate adjusted rate ratios (RRs) with 95% confidence intervals (CIs) for injury with each SMR base-pair + candidate interacting precipitant (i.e., triad) versus the SMR-containing base-pair alone. RESULTS: Among 58 478 triads, 29 were significantly positively associated with injury; confounder-adjusted RRs ranged from 1.39 (95% CI = 1.01-1.91) for tizanidine + omeprazole with gabapentin to 2.23 (95% CI = 1.02-4.87) for tizanidine + diclofenac with alprazolam. Most identified 3DI signals are new and have not been formally investigated. CONCLUSION: We identified 29 SMR 3DI signals associated with increased rates of injury. Future aetiologic studies should confirm or refute these SMR 3DI signals.
引用
- Chen C, Hennessy S, Brensinger CM, et al. Skeletal muscle relaxant drug-drug-drug interactions and unintentional traumatic injury: Screening to detect three-way drug interaction signals. Br J Clin Pharmacol. 2022. PMID: 35562168. doi:10.1111/bcp.15395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。